Mangrove Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,026
Closed -$104K 515
2025
Q4
$104K Buy
+26,026
New +$115K 0.01% 351

Other funds holding NBP

Mangrove Partners's NBP Position: Q1 2026 in Review

Mangrove Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 26,026 shares — an estimated $104K sold.

Mangrove Partners first reported a position in NBP in Q4 2025 and held it in 1 quarter. The position peaked at $104K in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Mangrove Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Mangrove Partners sold 26,026 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $104K.
  • Mangrove Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and held it in 1 quarter.
  • Mangrove Partners's NovaBridge Biosciences American Depositary Shares position peaked at $104K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Mangrove Partners's 13F filing for Q1 2026, filed 15 May 2026.